Breaking News Instant updates and real-time market news.

FTXP

Foothills Exploration

$0.00 /

+ (+0.00%)

09:35
01/21/20
01/21
09:35
01/21/20
09:35

Foothills Exploration says has no plans to do a reverse-split

Foothills Exploration provides an update to its shareholders. The company said, : First, we acknowledge that we are late in filing our most recent 10-Q report. We are working to be on file with the Commission as soon as possible. Against a backdrop of recent pricing pressure on Foothills' common stock, we would like to provide an update of our 2020 outlook and reiterate our investor communication practices...Developing the Company's Wind River Basin properties, consisting of 16,387 acres is a key priority for the Company in 2020. The Board of Directors believes that the Beaver Creek East Project has the potential to be a transformational asset for its stakeholders. The Board is excited about this prospective exploration project, where a third-party engineering firm issued an assessment that indicates Prospective Resources of approximately 21 million barrels of undiscovered oil, with a PV-10 value of $372M...The Company's technical team believes that there are additional non-conventional and other resource opportunities on the 16,387-acre leasehold, which could potentially increase the Prospective Resources outlook substantially. Foothills' technical team has put together a comprehensive geological and geophysical program to evaluate the full universe of data available in order to execute a favorable exploration drilling program. Foothills' acreage is located in this large undrilled area and is along the eastern flank of a deeper sub basin in the Wind River Basin proper, where a deep structural deposit called the Beaver Creek field has produced approximately 72.3 million barrels of oil and 917,129, 777 MCF of gas. The Big Sand Draw field, updip to the south, has produced some 61.4 million barrels of oil and 232,882,376 MCF of gas from multi-pay horizons generally in the Frontier, Muddy, Lakota, Morrison, Phosphoria, Tensleep and Madison formations. Based on our internal correlative analysis of adjacent fields, the size and scope of this project, if successful, could lead to a development program including primary, secondary and tertiary recovery, which possibly could recover over a billion dollars' worth of hydrocarbons at today's commodity prices. The Company needs to raise approximately $12M to begin the initial stages of Beaver Creek East development program and is currently exploring various forms of non-dilutive project financing including joint-ventures and farmout agreements. The Company owes an aggregate of approximately $2.9M to ten different variable-rate convertible noteholders, a number of which have started to convert sums due into common stock, pursuant to their respective note agreements. Approximately 27% of the total amount outstanding is collateralized by the Greater Green River Project with a single lender. Failure to meet the obligations of this lender could result in the sale or divestiture of this asset. Management is actively working to raise the necessary financing to meet it debt and regulatory obligations on the asset. With that said, Company management has been in ongoing discussions regarding payment of its notes with all of its debtholders. Management is currently working with the parties to either extend or repay the obligations to their satisfaction. Nevertheless, in the absence of an agreement with these parties, management remains committed to considering all available pathways to refinance or repay the notes so it can execute its business plan. Currently Foothills has 100,693,521 shares of common stock issued and outstanding. At the present time, the Company has no plans to do a reverse-split. In order to execute its business plan and create value, the Company will need to raise additional capital and reduce debt. The Company is looking at various non-dilutive options to finance its business initiatives and unlock shareholder value. The Company has had and will continue to have discussions with potential drilling and joint venture partners; however, it should be noted that there can be no assurance that the exploration of financing alternatives will result in a transaction."

TODAY'S FREE FLY STORIES

Conference/Events
The ASTCT and CIBMTR to hold a joint meeting » 08:09
02/19/20
02/19
08:09
02/19/20
08:09
ABBV

AbbVie

$93.60 /

-0.47 (-0.50%)

, ADPT

Adaptive Biotechnologies

$31.75 /

+0.29 (+0.92%)

, AMGN

Amgen

$221.74 /

-1.58 (-0.71%)

, ATNM

Actinium Pharmaceuticals

$0.25 /

-0.0132 (-5.09%)

, ATRA

Atara Biotherapeutics

$14.55 /

+0.3 (+2.11%)

, AZN

AstraZeneca

$49.17 /

+1.3 (+2.72%)

, BLUE

Bluebird Bio

$88.16 /

-0.98 (-1.10%)

, CDNA

CareDx

$27.15 /

+0.48 (+1.80%)

, CDTX

Cidara Therapeutics

$3.08 /

+0.1 (+3.36%)

, CELG

Bought by BMY

$0.00 /

+ (+0.00%)

, EQ

Equillium

$5.04 /

+0.06 (+1.20%)

, GMDA

Gamida Cell

$4.76 /

+0.035 (+0.74%)

, GSK

GlaxoSmithKline

$43.55 /

-0.19 (-0.43%)

, HUM

Humana

$372.26 /

-3.815 (-1.01%)

, INCY

Incyte

$79.25 /

+0.83 (+1.06%)

, JAZ

Jazz Technologies

$0.00 /

+ (+0.00%)

, KDMN

Kadmon

$4.85 /

+0.325 (+7.19%)

, MGTA

Magenta Therapeutics

$12.56 /

+0.2 (+1.62%)

, MRK

Merck

$82.46 /

-0.18 (-0.22%)

, NVS

Novartis

$97.21 /

-0.465 (-0.48%)

, PFE

Pfizer

$36.31 /

-0.18 (-0.49%)

, RCKT

Rocket Pharmaceuticals

$25.18 /

+1.18 (+4.92%)

, SGEN

Seattle Genetics

$119.99 /

+1.9 (+1.61%)

, SNY

Sanofi

$51.14 /

+1.21 (+2.42%)

, TAK

Takeda Pharmaceutical

$19.15 /

-0.29 (-1.49%)

American Society for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Tencent Music downgraded to Perform at Oppenheimer » 08:08
02/19/20
02/19
08:08
02/19/20
08:08
TME

Tencent Music

$12.68 /

-0.46 (-3.50%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Groupon says Q4 results disappointing 'on nearly every measure' » 08:08
02/19/20
02/19
08:08
02/19/20
08:08
GRPN

Groupon

$3.02 /

+0.175 (+6.15%)

Comments taken from Q4…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Signature Bank initiated with a Neutral at DA Davidson » 08:08
02/19/20
02/19
08:08
02/19/20
08:08
SBNY

Signature Bank

$144.32 /

+0.03 (+0.02%)

DA Davidson analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
10x Genomics price target raised to $95 from $65 at JPMorgan » 08:08
02/19/20
02/19
08:08
02/19/20
08:08
TXG

10x Genomics

$89.84 /

-2.605 (-2.82%)

JPMorgan analyst Tycho…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Tech Data expands AWS cloud support capabilities with nOps partnership » 08:07
02/19/20
02/19
08:07
02/19/20
08:07
TECD

Tech Data

$144.15 /

+0.07 (+0.05%)

, AMZN

Amazon.com

$2,153.54 /

+18.46 (+0.86%)

Tech Data (TECD)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Analog Devices sees Q2 adj. EPS $1.10 +/- 8c, consensus $1.13 » 08:07
02/19/20
02/19
08:07
02/19/20
08:07
ADI

Analog Devices

$118.50 /

+0.91 (+0.77%)

Sees Q2 revenue $1.35B…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Citigroup to hold a conference » 08:06
02/19/20
02/19
08:06
02/19/20
08:06
APTV

Aptiv

$88.02 /

-0.31 (-0.35%)

, ATKR

Atkore

$41.97 /

-0.2 (-0.47%)

, AXL

American Axle

$8.27 /

-0.49 (-5.59%)

, CP

Canadian Pacific

$268.97 /

-1.77 (-0.65%)

, CSX

CSX

$79.50 /

-0.1 (-0.13%)

, FTV

Fortive

$77.66 /

-0.135 (-0.17%)

, GTES

Gates Industrial

$12.75 /

-0.48 (-3.63%)

, JCI

Johnson Controls

$42.00 /

+0.05 (+0.12%)

, KSU

Kansas City Southern

$177.11 /

+3.33 (+1.92%)

, LDOS

Leidos

$123.26 /

+10.34 (+9.16%)

, LMT

Lockheed Martin

$435.37 /

-2.41 (-0.55%)

, MKSI

MKS Instruments

$113.95 /

-4.07 (-3.45%)

, MMM

3M

$158.83 /

-2.16 (-1.34%)

, MOC

Command Security

$0.00 /

+ (+0.00%)

, MTZ

MasTec

$60.53 /

+ (+0.00%)

, R

Ryder

$38.43 /

-1.71 (-4.26%)

, ROK

Rockwell Automation

$198.77 /

-1.88 (-0.94%)

, TKR

Timken

$53.53 /

-0.65 (-1.20%)

, URI

United Rentals

$153.90 /

-2.95 (-1.88%)

2020 Global Industrials…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
resTORbio initiates process to evaluate financial, strategic alternatives » 08:06
02/19/20
02/19
08:06
02/19/20
08:06
TORC

resTORbio

$1.34 /

-0.02 (-1.48%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
ASGN downgraded to Hold on 'new normal' of slower growth at Jefferies » 08:06
02/19/20
02/19
08:06
02/19/20
08:06
ASGN

ASGN

$61.79 /

-1.2 (-1.91%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
resTORbio announces interim results for Phase 1b/2a trial of RTB101 » 08:06
02/19/20
02/19
08:06
02/19/20
08:06
TORC

resTORbio

$1.34 /

-0.02 (-1.48%)

resTORbio announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
South Central College to hold a symposium » 08:05
02/19/20
02/19
08:05
02/19/20
08:05

12th Annual Ag Symposium…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
Analog Devices reports Q1 EPS $1.03, consensus $1.00 » 08:05
02/19/20
02/19
08:05
02/19/20
08:05
ADI

Analog Devices

$118.50 /

+0.91 (+0.77%)

Reports Q1 revenue $1.3B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
JPMorgan says be long Qorvo, Skyworks into seocnd half 5G ramps » 08:05
02/19/20
02/19
08:05
02/19/20
08:05
QRVO

Qorvo

$103.20 /

-2.76 (-2.60%)

, SWKS

Skyworks

$116.76 /

-2.28 (-1.92%)

JPMorgan analyst Bill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Federal Reserve Bank of Cleveland president to speak at a forum » 08:05
02/19/20
02/19
08:05
02/19/20
08:05

Cleveland Federal Reserve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
U.S. housing starts preview: starts should dip to a 1.390 M pace in January, » 08:05
02/19/20
02/19
08:05
02/19/20
08:05

U.S. housing starts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
DelMar Pharma enrolls final patient in Phase 2 trial of brain tumor candidate » 08:04
02/19/20
02/19
08:04
02/19/20
08:04
DMPI

DelMar Pharmaceuticals

$0.55 /

+0.0097 (+1.80%)

DelMar Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Cellectar says CLR 131 achieves primary efficacy endpoints in Phase 2 study » 08:04
02/19/20
02/19
08:04
02/19/20
08:04
CLRB

Cellectar Biosciences

$3.09 /

+0.19 (+6.55%)

Cellectar Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Myomo signs payer network agreement with Homelink » 08:04
02/19/20
02/19
08:04
02/19/20
08:04
MYO

Myomo

$5.40 /

-0.28 (-4.93%)

Myomo announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Salesforce price target raised to $217 from $192 at Wedbush » 08:04
02/19/20
02/19
08:04
02/19/20
08:04
CRM

Salesforce

$191.09 /

+1.18 (+0.62%)

Wedbush analyst Steve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Federal Reserve Bank of Atlanta president participates in a meeting » 08:04
02/19/20
02/19
08:04
02/19/20
08:04

Atlanta Federal Reserve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
Royal Caribbean downgraded to Hold from Buy at Argus » 08:02
02/19/20
02/19
08:02
02/19/20
08:02
RCL

Royal Caribbean

$111.39 /

-1.79 (-1.58%)

Argus analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Enphase Energy price target raised to $49 from $45 at Cowen » 08:02
02/19/20
02/19
08:02
02/19/20
08:02
ENPH

Enphase Energy

$40.37 /

-0.68 (-1.66%)

Cowen analyst Jeffrey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Splunk price target raised to $195 from $180 at Wedbush » 08:01
02/19/20
02/19
08:01
02/19/20
08:01
SPLK

Splunk

$172.91 /

+0.6 (+0.35%)

Wedbush analyst Steve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Sinotruk initiated with a Buy at Jefferies » 08:01
02/19/20
02/19
08:01
02/19/20
08:01
SHKLY

Sinotruk

$0.00 /

+ (+0.00%)

Jefferies analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.